Neptune Technologies & Bioressources Company Profile (CVE:NTB)

About Neptune Technologies & Bioressources

Neptune Technologies & Bioressources logoNeptune Technologies & Bioressources Inc. (Neptune) is a biotechnology company. The Company is engaged primarily in the development, manufacture and commercialization of marine-derived omega-3 polyunsaturated fatty acids (PUFAs). The Company operates in three segments: Neptune, Acasti Pharma Inc. and Acasti Pharma Inc. Its Neptune produces and commercializes nutraceutical products. Its Acasti Pharma Inc. develops and commercializes pharmaceutical applications for cardiovascular diseases. Its NeuroBioPharm Inc. develops and commercializes pharmaceutical applications for neurological diseases. It produces omega-3 PUFAs through its patented process of extracting oils from Antartic krill, which omega-3 PUFAs are then principally sold as bulk oil to Neptune's distributors who commercialize them under their private label primarily in the United States, European and Australian nutraceutical markets. The Company's products include Neptune Krill Oil (NKO) and ECOKRILL Oil (EKO).

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: CVE
  • Symbol: NTB
  • CUSIP:
Key Metrics:
  • Previous Close: $0.00
  • 50 Day Moving Average: $2
  • 200 Day Moving Average: $1
  • 52-Week Range: C$77,945,000.00 - C$1.08
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0
  • Market Cap: $N/A
  • Outstanding Shares: 77,945,000
Additional Links:

Analyst Ratings

Consensus Ratings for Neptune Technologies & Bioressources (CVE:NTB) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Neptune Technologies & Bioressources (CVE:NTB)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Neptune Technologies & Bioressources (CVE:NTB)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/16/2014($0.08)($0.06)ViewN/AView Earnings Details
5/22/2014($0.08)($0.08)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Neptune Technologies & Bioressources (CVE:NTB)
Current Year EPS Consensus Estimate: $0.02 EPS

Dividends

Dividend History for Neptune Technologies & Bioressources (CVE:NTB)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Neptune Technologies & Bioressources (CVE:NTB)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/1/2016James Stuart HamiltonDirectorBuy4,000C$1.58C$6,320.00
1/28/2016James Stuart HamiltonDirectorBuy2,000C$1.55C$3,100.00
1/18/2016Mario ParadisInsiderBuy10,000C$1.50C$15,000.00
1/15/2016John Morris MoretzDirectorBuy700,651C$1.05C$735,683.55
1/15/2016Mario ParadisInsiderBuy40,000C$1.54C$61,672.00
10/29/2015John Morris MoretzDirectorBuy26,044C$1.08C$28,101.48
10/28/2015John Morris MoretzDirectorBuy24,500C$1.12C$27,538.00
10/27/2015John Morris MoretzDirectorBuy5,500C$1.09C$6,006.00
10/23/2015John Morris MoretzDirectorBuy50,000C$1.17C$58,385.00
10/5/2015John Morris MoretzDirectorBuy13,692C$1.24C$16,991.77
10/2/2015John Morris MoretzDirectorBuy33,900C$1.23C$41,663.10
9/15/2015John Morris MoretzDirectorBuy9,001C$1.24C$11,161.24
7/22/2015John Morris MoretzDirectorBuy2,800C$1.34C$3,750.60
7/21/2015John Morris MoretzDirectorBuy21,654C$1.34C$28,975.22
7/16/2015Pierre LemieuxDirectorSell6,250C$1.62C$10,135.00
6/8/2015Pierre FitzgibbonDirectorBuy47,500C$1.70C$80,693.00
2/17/2015Reed TucksonDirectorBuy10,800C$1.85C$19,931.40
2/13/2015Michel TimperioInsiderSell10,000C$2.19C$21,870.00
2/6/2015André GodinInsiderSell5,000C$2.14C$10,700.00
2/5/2015Michel TimperioInsiderSell15,000C$2.11C$31,680.00
1/30/2015Bel Dominique LeInsiderSell15,000C$2.30C$34,500.00
1/29/2015Bel Dominique LeInsiderSell10,000C$2.25C$22,500.00
1/22/2015Claudie LauzonInsiderSell8,334C$2.04C$16,966.36
1/22/2015Pierre LemieuxDirectorSell11,250C$2.00C$22,500.00
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Neptune Technologies & Bioressources (CVE:NTB)
DateHeadline
News IconDr. Tina Sampalis M.D., Ph.D. Joins Relevium’s Board of Directors (CVE:NTB)
www.military-technologies.net - February 10 at 7:49 PM
seekingalpha.com logoInterview: Neptune Wellness Solutions CEO Jim Hamilton (CVE:NTB)
seekingalpha.com - February 2 at 7:48 PM
News IconAfter Forming Bearish Head & Shoulders, Is Neptune Technologies & Bioressources-Ord (NEPT)’s Near-Term Analysis Negative? (CVE:NTB)
randolphguide.com - January 31 at 12:35 AM
News IconGlobal Omega-3 Fatty Acid Sales Industry Forecast to 2021 with Key Companies Profile, Supply, Demand, Cost Structure, and SWOT Analysis (CVE:NTB)
empowerednews.net - January 26 at 11:37 PM
finance.yahoo.com logoRequested symbol wasn't found (CVE:NTB)
ca.finance.yahoo.com - January 18 at 7:30 PM
finance.yahoo.com logoEdited Transcript of NTB.TO earnings conference call or presentation 12-Jan-17 10:30pm GMT (CVE:NTB)
finance.yahoo.com - January 13 at 11:13 PM
stockhouse.com logoNEPTUNE TECHNOLOGIES BIORESSOURCES INC (CVE:NTB)
www.stockhouse.com - January 13 at 12:32 AM
finanznachrichten.de logoNeptune Announces Record Third Quarter Results / Revenue Increases 122% YoY to $12.3 million (CVE:NTB)
www.finanznachrichten.de - January 12 at 7:32 PM
4-traders.com logoNeptune Technologies & Bioressources : Announces Record Third Quarter Results (CVE:NTB)
www.4-traders.com - January 12 at 7:32 PM
News IconNeptune to Hold Conference Call to Discuss Third Quarter Results for the Period Ended November ... (CVE:NTB)
www.biomedreports.com - January 4 at 7:43 PM
News IconGlobal Omega-3 Fatty Acid Industry Forecast to 2021 with Key Companies Profile, Supply, Demand, Cost Structure, and SWOT Analysis (CVE:NTB)
empowerednews.net - January 2 at 6:47 PM
live-pr.com logoNew Report Available: Acasti Pharma Inc. (APO) - Financial and Strategic SWOT Analysis Review (CVE:NTB)
www.live-pr.com - December 23 at 7:04 PM
4-traders.com logoNeptune Technologies & Bioressources : Sourcing Colors of the Rainbow Through the Winter (CVE:NTB)
www.4-traders.com - November 30 at 11:41 AM
einnews.com logoGlobal Advanced Composites Market 2016 Share, Trend, Segmentation and Forecast to 2021 (CVE:NTB)
automotive.einnews.com - November 7 at 10:21 AM
News IconNeptune and Ingenutra Sign Agreement for MaxSimil (CVE:NTB)
www.nutraceuticalsworld.com - October 11 at 6:46 PM
News IconNeptune and Aker BioMarine Unveil Patent Agreement (CVE:NTB)
www.nutraceuticalsworld.com - October 5 at 11:41 AM
live-pr.com logoNewly released market study: Acasti Pharma Inc. (APO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile (CVE:NTB)
www.live-pr.com - September 21 at 10:36 AM
News IconIs Acasti Pharma Inc (NASDAQ:ACST) About To Disrupt A Billion Dollar Industry? (CVE:NTB)
streetregister.com - September 17 at 10:54 AM
News IconOmega-3 Fatty Acid Market Growth and Demand Forecast to 2020 (CVE:NTB)
www.prlog.org - August 23 at 10:57 AM
News IconSupplier Briefs: September 2016 (CVE:NTB)
www.wholefoodsmagazine.com - August 19 at 9:33 AM
4-traders.com logoNeptune Technologies & Bioressources : Announces the Election of its Directors and Change of Fiscal Year End (CVE:NTB)
www.4-traders.com - July 15 at 11:21 AM
finance.yahoo.com logoEdited Transcript of NTB.TO earnings conference call or presentation 26-May-16 12:30pm GMT (CVE:NTB)
finance.yahoo.com - May 26 at 11:08 AM
stockhouse.com logoNeptune Technologies & Bioressources Inc T.NTB (CVE:NTB)
www.stockhouse.com - January 31 at 6:40 PM
live-pr.com logoNew Market Research Report: Neptune Technologies & Bioressources, Inc. (CVE:NTB)
www.live-pr.com - January 29 at 11:52 AM
streetinsider.com logoForm SC 13G Neptune Technologies & Filed by: Schottenfeld Richard (CVE:NTB)
www.streetinsider.com - January 21 at 6:24 PM
finance.yahoo.com logoEdited Transcript of NTB.TO earnings conference call or presentation 13-Jan-16 1:30pm GMT (CVE:NTB)
finance.yahoo.com - January 13 at 10:51 AM
biz.yahoo.com logoQ3 2016 Neptune Technologies & Bioressources Inc Earnings Release - After Market Close (CVE:NTB)
biz.yahoo.com - January 12 at 7:07 AM

Social

What is Neptune Technologies & Bioressources' stock symbol?

Neptune Technologies & Bioressources trades on the Canadian Venture Exchange (CVE) under the ticker symbol "NTB."

How do I buy Neptune Technologies & Bioressources stock?

Shares of Neptune Technologies & Bioressources and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

How much does a share of Neptune Technologies & Bioressources stock cost?

One share of Neptune Technologies & Bioressources stock can currently be purchased for approximately C$1.50.

Neptune Technologies & Bioressources (CVE:NTB) Chart for Monday, February, 27, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Neptune Technologies & Bioressources (CVE:NTB)

Earnings History Chart

Earnings by Quarter for Neptune Technologies & Bioressources (CVE:NTB)

Dividend History Chart

Dividend Payments by Quarter for Neptune Technologies & Bioressources (CVE:NTB)

Last Updated on 2/27/2017 by MarketBeat.com Staff